联邦对阿片类药物流行的反应

Alexus Witherell
{"title":"联邦对阿片类药物流行的反应","authors":"Alexus Witherell","doi":"10.52214/cujgh.v12i2.9918","DOIUrl":null,"url":null,"abstract":"The opioid epidemic has been a major public health crisis since the 1990s but was only declared a federal public health emergency in 2017. Since then, the federal government has increased funding to states for programs to address opioid use and overdose deaths. Despite the increased funding in the past five years, opioid-related overdose deaths continue to rise.\nThe Substance Abuse and Mental Health Administration (SAMHSA) is the major federal agency responsible for allocating federal funds to opioid use disorder prevention, treatment, and personnel training programs. In 2021, SAMHSA allocated funding for opioid use disorder through eleven grant programs with a total of 330 grant awards, amounting to over $150 million. My analysis of 2021 SAMHSA grants aims to identify how funds for opioid use disorder are allocated, examine the relationship between opioid-related overdose deaths and the amount of funding allocated to states, and suggest potential gaps in funding.\nUltimately, my research has found that treatment-focused programs were prioritized over prevention and education or training programs by SAMHSA funding. In 2021, treatment programs accounted for 223 of the 330 individual SAMHSA grant awards for opioid use disorder and 100% of grant awards received by nonprofit organizations. Medication-Assisted Treatment is the most commonly funded program among these grant awards.\nAdditionally, states with a higher number of opioid-related overdose deaths are more likely to receive higher funding from SAMHSA grants (p<.001). Conversely, states with higher overdose death crude rates per 100,000 people did not receive adequate funding relative to the size of the population, creating gaps in accessibility to care. Additional gaps in opioid use disorder programs exist due to the downstream focus of funded interventions, neglecting upstream interventions.\nThe data in my research are limited and therefore cannot draw broader conclusions as to how funding influences overdose deaths over time.           ","PeriodicalId":128122,"journal":{"name":"The Columbia University Journal of Global Health","volume":"514 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Federal Response to the Opioid Epidemic\",\"authors\":\"Alexus Witherell\",\"doi\":\"10.52214/cujgh.v12i2.9918\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The opioid epidemic has been a major public health crisis since the 1990s but was only declared a federal public health emergency in 2017. Since then, the federal government has increased funding to states for programs to address opioid use and overdose deaths. Despite the increased funding in the past five years, opioid-related overdose deaths continue to rise.\\nThe Substance Abuse and Mental Health Administration (SAMHSA) is the major federal agency responsible for allocating federal funds to opioid use disorder prevention, treatment, and personnel training programs. In 2021, SAMHSA allocated funding for opioid use disorder through eleven grant programs with a total of 330 grant awards, amounting to over $150 million. My analysis of 2021 SAMHSA grants aims to identify how funds for opioid use disorder are allocated, examine the relationship between opioid-related overdose deaths and the amount of funding allocated to states, and suggest potential gaps in funding.\\nUltimately, my research has found that treatment-focused programs were prioritized over prevention and education or training programs by SAMHSA funding. In 2021, treatment programs accounted for 223 of the 330 individual SAMHSA grant awards for opioid use disorder and 100% of grant awards received by nonprofit organizations. Medication-Assisted Treatment is the most commonly funded program among these grant awards.\\nAdditionally, states with a higher number of opioid-related overdose deaths are more likely to receive higher funding from SAMHSA grants (p<.001). Conversely, states with higher overdose death crude rates per 100,000 people did not receive adequate funding relative to the size of the population, creating gaps in accessibility to care. Additional gaps in opioid use disorder programs exist due to the downstream focus of funded interventions, neglecting upstream interventions.\\nThe data in my research are limited and therefore cannot draw broader conclusions as to how funding influences overdose deaths over time.           \",\"PeriodicalId\":128122,\"journal\":{\"name\":\"The Columbia University Journal of Global Health\",\"volume\":\"514 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Columbia University Journal of Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52214/cujgh.v12i2.9918\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Columbia University Journal of Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52214/cujgh.v12i2.9918","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

自上世纪90年代以来,阿片类药物的流行一直是一场重大的公共卫生危机,但直到2017年才被宣布为联邦突发公共卫生事件。从那时起,联邦政府增加了对各州的资金,用于解决阿片类药物使用和过量死亡问题。尽管过去五年资金有所增加,但与阿片类药物有关的过量死亡人数继续上升。药物滥用和精神健康管理局(SAMHSA)是负责为阿片类药物使用障碍预防、治疗和人员培训项目分配联邦资金的主要联邦机构。2021年,SAMHSA通过11个赠款项目为阿片类药物使用障碍划拨资金,共有330个赠款,总额超过1.5亿美元。我对2021年SAMHSA拨款的分析旨在确定如何分配用于阿片类药物使用障碍的资金,研究阿片类药物相关的过量死亡与分配给各州的资金数量之间的关系,并提出资金方面的潜在缺口。最终,我的研究发现,在SAMHSA的资助下,以治疗为重点的项目优先于预防、教育或培训项目。2021年,治疗项目占330个SAMHSA阿片类药物使用障碍补助金中的223个,占非营利组织获得的补助金的100%。药物辅助治疗是这些资助奖项中最常见的资助项目。此外,阿片类药物过量死亡人数较多的州更有可能从SAMHSA拨款中获得更多的资金(p< 0.001)。相反,与人口规模相比,每10万人中过量死亡率较高的州没有获得足够的资金,从而在获得护理方面造成了差距。由于资助干预措施的下游重点,忽视了上游干预措施,阿片类药物使用障碍规划存在更多空白。我的研究数据有限,因此无法得出更广泛的结论,即资金如何随着时间的推移影响过量死亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Federal Response to the Opioid Epidemic
The opioid epidemic has been a major public health crisis since the 1990s but was only declared a federal public health emergency in 2017. Since then, the federal government has increased funding to states for programs to address opioid use and overdose deaths. Despite the increased funding in the past five years, opioid-related overdose deaths continue to rise. The Substance Abuse and Mental Health Administration (SAMHSA) is the major federal agency responsible for allocating federal funds to opioid use disorder prevention, treatment, and personnel training programs. In 2021, SAMHSA allocated funding for opioid use disorder through eleven grant programs with a total of 330 grant awards, amounting to over $150 million. My analysis of 2021 SAMHSA grants aims to identify how funds for opioid use disorder are allocated, examine the relationship between opioid-related overdose deaths and the amount of funding allocated to states, and suggest potential gaps in funding. Ultimately, my research has found that treatment-focused programs were prioritized over prevention and education or training programs by SAMHSA funding. In 2021, treatment programs accounted for 223 of the 330 individual SAMHSA grant awards for opioid use disorder and 100% of grant awards received by nonprofit organizations. Medication-Assisted Treatment is the most commonly funded program among these grant awards. Additionally, states with a higher number of opioid-related overdose deaths are more likely to receive higher funding from SAMHSA grants (p<.001). Conversely, states with higher overdose death crude rates per 100,000 people did not receive adequate funding relative to the size of the population, creating gaps in accessibility to care. Additional gaps in opioid use disorder programs exist due to the downstream focus of funded interventions, neglecting upstream interventions. The data in my research are limited and therefore cannot draw broader conclusions as to how funding influences overdose deaths over time.           
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信